DecisionPoint Financial’s AbbVie ABBV Stock Holding History

DecisionPoint Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.96K	Sell	32 -16	-33%	-$3.55K	﹤0.01%	203
2025 Q4	$11K	Buy	48 +16	+50%	+$3.65K	﹤0.01%	190
2025 Q3	$7.82K	Hold	32	–	–	﹤0.01%	152
2025 Q2	$6.08K	Buy	+32	New	+$5.95K	﹤0.01%	168
2023 Q4	–	Sell	-35	Closed	-$5.22K	–	211
2023 Q3	$5.22K	Hold	35	–	–	﹤0.01%	155
2023 Q2	$4.72K	Hold	35	–	–	﹤0.01%	141
2023 Q1	$5.58K	Hold	35	–	–	﹤0.01%	130
2022 Q4	$5.66K	Buy	+35	New	+$5.37K	﹤0.01%	110

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DecisionPoint Financial's ABBV Position: Q1 2026 in Review

DecisionPoint Financial reduced its AbbVie (ABBV) stake by 33% in Q1 2026, selling an estimated $3.55K and leaving 32 shares worth $6.96K. The position accounts for ﹤0.01% of the portfolio, ranked #203.

DecisionPoint Financial first reported a position in ABBV in Q4 2022 and has held it in 8 quarters since. The position peaked at $11K in Q4 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

DecisionPoint Financial held 32 shares of AbbVie worth $6.96K as of Q1 2026.
DecisionPoint Financial sold 16 AbbVie shares in Q1 2026, an estimated $3.55K.
AbbVie made up ﹤0.01% of DecisionPoint Financial's portfolio in Q1 2026, its #203 holding.
DecisionPoint Financial first reported a position in AbbVie in Q4 2022 and has held it in 8 quarters since.
DecisionPoint Financial's AbbVie position peaked at $11K in Q4 2025.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on DecisionPoint Financial's 13F filing for Q1 2026, filed 6 May 2026.